GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals Migraine
Pfizer Trumpets Lancet Publication Of Migraine Drug’s Phase 3 Results
2023-02-18
Trials & Approvals HIV Treatment
ViiV Healthcare to Present First Head-to-head Data for New HIV Treatment Regimen Cabenuva Against Biktarvy
2023-02-15
Regulatory photodynamic therapy
FDA Slaps Refusal to File Letter on Soligenix’s Photodynamic Cancer Therapy Application
2023-02-14
Trials & Approvals Biosimilar
Biocon and Viatris Hit Another FDA Wall with Avastin Biosimilar
2023-02-13
Trials & Approvals Diabetic Macular Edema
Roche’s Vision Loss Drug Clocks Two Phase 3 Wins In Macular Edema
2023-02-13
Trials & Approvals Gene Therapy
Immusoft’s B Cell Gene Therapy Gets FDA Nod to Enter Clinical Trials
2023-02-13
Trials & Approvals IgA NephropathySouth Korea
South Korea Puts Everest Medicines’ Nefecon On Fast Track
2023-02-10
Trials & Approvals Heart Failure
AstraZeneca’s Forxiga Gets EU Nod To Treat Symptomatic Chronic Heart Failure
2023-02-08
Trials & Approvals Major Depressive Disorder
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
Trials & Approvals Hereditary Angioedema
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Trials & Approvals Arrhythmias
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
Trials & Approvals Marburg Virus
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Trials & Approvals Anemia
GSK’s Jesduvroq Wins FDA Approval for First Oral Drug for Anemia In Chronic Kidney Disease
2023-02-02
Trials & Approvals Biosimilar
Amgen’s Humira Biosimilar Now Available in the U.S.
2023-02-01
Trials & Approvals Breast Cancer
Menarini’s Oral SERD Gains First-Ever FDA Approval for Breast Cancer
2023-01-30
1 … 4 5 6 7 8 … 50
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top